346 related articles for article (PubMed ID: 20457278)
1. Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
Ly KH; Régent A; Tamby MC; Mouthon L
Autoimmun Rev; 2010 Aug; 9(10):635-45. PubMed ID: 20457278
[TBL] [Abstract][Full Text] [Related]
2. [Giant-cell arteritis pathogenesis].
Samson M; Bonnotte B
Presse Med; 2012 Oct; 41(10):937-47. PubMed ID: 22902103
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells.
Samson M; Audia S; Martin L; Janikashvili N; Bonnotte B
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S65-73. PubMed ID: 23663684
[TBL] [Abstract][Full Text] [Related]
4. Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling.
Rodríguez-Pla A; Bosch-Gil JA; Rosselló-Urgell J; Huguet-Redecilla P; Stone JH; Vilardell-Tarres M
Circulation; 2005 Jul; 112(2):264-9. PubMed ID: 15998676
[TBL] [Abstract][Full Text] [Related]
5. Immunopathways in giant cell arteritis and polymyalgia rheumatica.
Weyand CM; Ma-Krupa W; Goronzy JJ
Autoimmun Rev; 2004 Jan; 3(1):46-53. PubMed ID: 14871649
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis.
Kaiser M; Weyand CM; Björnsson J; Goronzy JJ
Arthritis Rheum; 1998 Apr; 41(4):623-33. PubMed ID: 9550471
[TBL] [Abstract][Full Text] [Related]
7. Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation.
Han JW; Shimada K; Ma-Krupa W; Johnson TL; Nerem RM; Goronzy JJ; Weyand CM
Circ Res; 2008 Mar; 102(5):546-53. PubMed ID: 18202318
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of giant cell arteritis].
Ly KH; Liozon E; Fauchais AL; Vidal E
Rev Med Interne; 2013 Jul; 34(7):392-402. PubMed ID: 23528439
[TBL] [Abstract][Full Text] [Related]
9. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Malmsjö M; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2009 May; 116(5):990-6. PubMed ID: 19410957
[TBL] [Abstract][Full Text] [Related]
10. [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].
Wagner AD
Ophthalmologe; 2006 Apr; 103(4):302-7. PubMed ID: 16541271
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in our understanding of giant cell arteritis pathogenesis.
Samson M; Corbera-Bellalta M; Audia S; Planas-Rigol E; Martin L; Cid MC; Bonnotte B
Autoimmun Rev; 2017 Aug; 16(8):833-844. PubMed ID: 28564617
[TBL] [Abstract][Full Text] [Related]
12. Vascular dendritic cells in giant cell arteritis.
Weyand CM; Ma-Krupa W; Pryshchep O; Gröschel S; Bernardino R; Goronzy JJ
Ann N Y Acad Sci; 2005 Dec; 1062():195-208. PubMed ID: 16461802
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathology of giant cell arteritis: From inflammation to vascular remodeling].
Régent A; Ly KH; Mouthon L
Presse Med; 2019 Sep; 48(9):919-930. PubMed ID: 31543394
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.
Andersson R; Hansson GK; Söderström T; Jonsson R; Bengtsson BA; Nordborg E
Clin Exp Immunol; 1988 Jul; 73(1):82-7. PubMed ID: 3048814
[TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis--a molecular approach to the multiple facets of the syndrome.
Weyand CM; Hafner V; Kaiser M; Goronzy JJ
Ann Med Interne (Paris); 1998 Nov; 149(7):420-4. PubMed ID: 9921395
[TBL] [Abstract][Full Text] [Related]
16. Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.
Dimitrijevic I; Andersson C; Rissler P; Edvinsson L
Ophthalmology; 2010 Mar; 117(3):628-36. PubMed ID: 20036012
[TBL] [Abstract][Full Text] [Related]
17. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.
Wagner AD; Goronzy JJ; Weyand CM
J Clin Invest; 1994 Sep; 94(3):1134-40. PubMed ID: 8083354
[TBL] [Abstract][Full Text] [Related]
18. [Pathology of giant cell arteritis].
Amouroux J
Ann Med Interne (Paris); 1998 Nov; 149(7):415-9. PubMed ID: 9921394
[TBL] [Abstract][Full Text] [Related]
19. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and pathophysiology of giant cell arteritis].
Greigert H; Bonnotte B; Samson M
Rev Prat; 2023 Apr; 73(4):380-386. PubMed ID: 37289150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
